Correlation between the presence of anti HPV33 VLP antibodies and HPV DNA in cervical neoplasia patients
Language English Country Austria Media print
Document type Journal Article, Research Support, Non-U.S. Gov't
PubMed
9125054
DOI
10.1007/s007050050087
Knihovny.cz E-resources
- MeSH
- DNA, Viral analysis MeSH
- Uterine Cervical Dysplasia immunology virology MeSH
- Humans MeSH
- Papillomaviridae genetics immunology isolation & purification MeSH
- Antibodies, Viral analysis immunology MeSH
- Virion immunology MeSH
- Check Tag
- Humans MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Names of Substances
- DNA, Viral MeSH
- Antibodies, Viral MeSH
The L1 capsid proteins derived from human papillomavirus (HPV) type 33 were expressed in a recombinant baculovirus system using Sf9 insect cells. Selected sera originating in women from case-control study carried out in Spain and Colombia found negative and positive for HPV16, 18, 31, 33 and 35 DNA were tested in ELISA for the presence of IgG antibodies to purified virus-like particles (VLP). The reactivity was type-restricted with the possible exception of HPV31.
References provided by Crossref.org
